| Biotechnology Industry | Healthcare Sector | - CEO | MSE Exchange | INE194N01016 ISIN |
| India Country | - Employees | 15 Mar 2022 Last Dividend | - Last Split | - IPO Date |
Genesis IBRC India Ltd. operates as a diversified holding company with a primary focus on promoting health and wellness. The company secures its position in the health industry by engaging in the healthcare, biotechnology, and nutraceutical sectors through its subsidiaries. It is dedicated to the research, development, and commercialization of wellness products, with a keen emphasis on harnessing biotechnological innovations. As global awareness towards health and the demand for sustainable lifestyle choices surge, Genesis IBRC India Ltd. plays a pivotal role in the preventive healthcare domain. Its activities in the emerging sectors of health and advanced biotechnological solutions reflect the dynamic shifts within the industry, underscoring its commitment to integrating state-of-the-art science in enhancing health outcomes as part of a broader global initiative.
At the core of its operations, Genesis IBRC India Ltd. offers comprehensive healthcare services aimed at improving patient care and wellness. This includes diagnostic services, treatment, and personalized healthcare solutions that cater to the specific needs of individuals, thereby elevating the standard of healthcare delivery.
The company is deeply involved in biotechnological research and development, focusing on the creation of groundbreaking scientific solutions. These innovations span various applications, from medical treatments to health supplements, driving progress in how diseases are treated and prevented.
Understanding the critical role of nutrition in health and wellbeing, Genesis IBRC India Ltd. develops and markets a variety of nutraceutical products. These products are designed to supplement the diet, support health maintenance, and prevent diseases, reflecting a natural approach towards sustaining health.